VerdeMed

Verdemed, a pharmaceutical company known for producing cannabis-derived products, has received five fresh approvals from the Brazilian Health Regulatory Agency (Agência Nacional de Vigilância Sanitária, Anvisa) in July. This accomplishment catapults the firm to a dominant...

The Benzinga Cannabis Capital Conference in Chicago, September 13-14, will celebrate the most recognized Latin American cannabis companies. This year's attendees will have the opportunity to meet the best Latin American brands in the industry that entered the emerging market and knew how to...

In a major regulatory win for the entire cannabis industry, the stringent Brazilian Health Regulatory Agency (Anvisa) has approved a cannabis-derived CBD 50 mg/ml product produced by Verdemed Pharmaceuticals, in partnership with Colombian-American operator Clever Leaves Holdings Inc (NASDAQ: CLVR...

The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Verdemed is a Canadian pharmaceutical cannabis company that is rooting its operations in Latin America. Verdemed's mission is to make...

Canadian cannabis startup VerdeMed has been expanding across Latin America. Over the last few months, the company started selling CBD products to select patients in Brazil, won four public bids to supply local governments with cannabis-derived products, and closed a deal to supply its products...

By Natalia Kesselman, originally published on El Planteo. Last Tuesday, September the 1st, the Brazilian Chamber of Representatives’ Special Commission in charge of regulating cannabis-based medicines held an online meeting in the form of a public hearing. The objective of the assembly was to...

The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga.   Verdemed, a Canadian pharmaceutical cannabis company, is on a mission to bring medicinal cannabis to Latin America.   As the...

The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Verdemed, a Canadian pharmaceutical cannabis company, is on a mission to bring cannabinoid-based medicinal products to Latin America. But...

The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. According to an article from Harvard Health Publishing, the most common use for medical marijuana in the United States is pain control -...

By José Bacellar, president and CEO at VerdeMed. Anvisa paves the way for the Brazilian Congress to create a regulatory framework for medical cannabis. Brazil joins a group of 47 countries, including Canada, Chile, Colombia, Germany, Portugal, and the United States that have approved the...

Cannabis 10x, a company that helps investors and companies find each other, hosted a round of investor pitches on the second day of the Benzinga Cannabis Capital Conference in Miami Beach.  Kadenwood Consumer brands will win the cannabis space in the long run, said Kadenwood CEO Erick Dickens...

Guests at the Benzinga Cannabis Capital Conference in Chicago last week heard from industry execs about their branding and corporate development during breakout sessions at the Palmer House.  VerdeMed  José Bacellar, president and CEO of Canadian pharmaceutical company...